Nebivolol/Hydrochlorothiazide Cristers (Hydrochlorothiazide, Nebivolol)

Nebivolol/Hydrochlorothiazide, the active ingredient in Nebivolol/Hydrochlorothiazide Cristers, is a beta‑blocker and thiazide diuretic presented as a tablet for oral use. It is prescribed to manage essential hypertension in adult patients. By combining a selective β1‑adrenergic blocker with a diuretic, the formulation helps lower blood pressure through complementary mechanisms.

GNH USA supplies Nebivolol/Hydrochlorothiazide Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol/Hydrochlorothiazide is indicated for conditions related to elevated blood pressure.

- Essential hypertension: lowers systolic and diastolic blood pressure in adult patients. - Hypertension: provides combined β1‑blockade and diuretic effect to achieve target blood pressure. - High blood pressure requiring combined therapy: simplifies treatment by addressing cardiac output and fluid volume simultaneously.

Nebivolol/Hydrochlorothiazide may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Dizziness: transient light‑headedness, especially after standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness or reduced energy. - Increased urination: due to the diuretic component. - Electrolyte imbalance: mild changes in potassium or sodium levels. - Cough: occasional dry throat irritation.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure leading to fainting. - Acute renal impairment: sudden decrease in kidney function. - Hyperuricemia or gout attacks: elevated uric acid levels. - Allergic reactions: rash, itching, or swelling. - Pancreatitis: abdominal pain with nausea. - Stevens‑Johnson syndrome: severe skin blistering.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood pressure: ensure adequate control without excessive drop. - Assess renal function: check creatinine and eGFR periodically. - Check electrolytes: especially potassium and sodium levels. - Use caution in asthma: β‑blockade may exacerbate bronchospasm. - Avoid abrupt discontinuation: taper to prevent rebound hypertension. - Store at room temperature: keep in the original pack, protect from moisture.

Nebivolol/Hydrochlorothiazide can interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid): - Other antihypertensives: risk of additive hypotension. - NSAIDs: may reduce diuretic efficacy and impair renal function. - Lithium: increased lithium levels leading to toxicity. - CYP2D6 inhibitors: elevate nebivolol plasma concentrations. - Potassium‑sparing diuretics: risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: enhanced renal effects, monitor kidney function. - Other beta‑blockers: additive cardiac depression. - Antidiabetic agents: possible hypoglycemia, monitor glucose. - Antidepressants (SSRIs): may affect blood pressure control. - Anticoagulants: monitor for bleeding risk due to potential platelet effects.